Abstract
We have observed that conditioning for hematopoietic transplantation by lethal irradiation induces a proteolytic microenvironment in the bone marrow (BM) that activates the complement cascade (CC). As a result, BM is enriched for proteolytic enzymes and the soluble form of the terminal product of CC activation, the membrane attack complex C5b-C9 (MAC). At the same time, proteolytic enzymes induced in irradiated BM impair the chemotactic activity of α-chemokine stromal-derived factor-1 (SDF-1). As SDF-1 is considered a crucial BM chemoattractant for transplanted hematopoietic stem/progenitor cells (HSPCs), we sought to determine whether other factors that are resistant to proteolytic enzymes have a role in this process, focusing on proteolysis-resistant bioactive lipids. We found that the concentrations of sphingosine-1-phosphate (S1P) and ceramide-1-phosphate (C1P) increase in the BM after conditioning for transplantation and that both S1P and, as we show here for the first time, C1P are potent chemoattractants for HSPCs. Next, we observed that C5-deficient mice that do not generate MAC show impaired engraftment of HSPCs. In support of a role for MAC in homing and engraftment, we found that soluble MAC enhances in a CR3 (CD11b/CD18)-dependent manner the adhesion of HSPCs to BM stromal cells and increases the secretion of SDF-1 by BM stroma. We conclude that an increase in BM levels of proteolytic enzyme-resistant S1P and C1P and activation of CC, which leads to the generation of MAC, has an important and previously underappreciated role in the homing of transplanted HSPCs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Levesque JP, Takamatsu Y, Nilsson SK, Haylock DN, Simmons PJ . Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 2001; 98: 1289–1297.
Peled A, Grabovsky V, Habler L, Sandbank J, Arenzana-Seisdedos F, Petit I et al. The chemokine SDF-1 stimulates integrin-mediated arrest of CD34+ cells on vascular endothelium under shear flow. J Clin Invest 1999; 104: 1199–1211.
Ratajczak MZ, Reca R, Wysoczynski M, Kucia M, Baran JT, Allendorf DJ et al. Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cells. Leukemia 2004; 18: 1482–1490.
Cho SY, Xu M, Roboz J, Lu M, Mascarenhas J, Hoffman R . The effect of CXCL12 processing on CD34+ cell migration in myeloproliferative neoplasms. Cancer Res 2010; 70: 3402–3410.
Lévesque JP, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ . Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 2003; 111: 187–196.
Ma Q, Jones D, Springer TA . The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 1999; 10: 463–471.
Christopherson II KW, Hangoc G, Mantel CR, Broxmeyer HE . Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 2004; 305: 1000–1003.
Onai N, Zhang YY, Yoneyama H, Kitamura T, Ishikawa S, Matsushima K . Impairment of lymphopoiesis and myelopoiesis in mice reconstituted with bone marrow-hematopoietic progenitor cells expressing SDF-1-intrakine. Blood 2000; 96: 2074–2080.
Fyrst H, Saba JD . An update on sphingosine-1-phosphate and other sphingolipid mediators. Nat Chem Biol 2010; 6: 489–497.
Hanel P, Andréani P, Graler MH . Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J 2007; 21: 1202–1209.
Ohkawa R, Nakamura K, Okubo S, Hosogaya S, Ozaki Y, Tozuka M et al. Plasma sphingosine-1-phosphate measurement in healthy subjects: close correlation with red blood cell parameters. Ann Clin Biochem 2008; 45: 356–363.
Mitsutake S, Kim TJ, Inagaki Y, Kato M, Yamashita T, Igarashi Y . Ceramide kinase is a mediator of calcium-dependent degranulation in mast cells. J Biol Chem 2004; 279: 17570–17577.
Lamour NF, Stahelin RV, Wijesinghe DS, Maceyka M, Wang E, Allegood JC et al. Ceramide kinase uses ceramide provided by ceramide transport protein: localization to organelles of eicosanoid synthesis. J Lipid Res 2007; 48: 1293–1304.
Reca R, Mastellos D, Majka M, Marquez L, Ratajczak J, Franchini S et al. Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1. Blood 2003; 101: 3784–3793.
Ratajczak MZ, Lee H, Wysoczynski M, Wan W, Marlicz W, Laughlin MJ et al. Novel insight into stem cell mobilization-plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complex. Leukemia 2010; 24: 976–985.
Hoggatt J, Singh P, Sampath J, Pelus LM . Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood 2009; 113: 5444–5455.
Lapidot T, Dar A, Kollet O . How do stem cells find their way home? Blood 2005; 106: 1901–1910.
Ponomaryov T, Peled A, Petit I, Taichman RS, Habler L, Sandbank J et al. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest 2000; 106: 13331–11339.
Hoggatt J, Pelus LM . Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor trafficking. Leukemia 2010; 24: 1993–2002.
Baron MH . Embryonic origins of mammalian hematopoiesis. Exp Hematol 2003; 31: 1160–1169.
Weissman I, Papaioannou V, Gardner R . Fetal hematopoietic origins of the adult hemolymphoid system. In: B Clarkson, P Mark, J Till (eds). Differentiation of Normal and Neoplastic Cells. Cold Spring Harbor Lab Press: New York, 1978, 33–47.
Luster AD, Alon R, von Andrian UH . Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol 2005; 6: 1182–1190.
Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004; 10: 858–864.
Kucia MJ, Wysoczynski M, Wu W, Zuba-Surma EK, Ratajczak J, Ratajczak MZ . Evidence that very small embryonic-like stem cells are mobilized into peripheral blood. Stem Cells 2008; 26: 2083–2092.
Greenbaum AM, Link DC . Mechanisms of G-CSF-mediated hematopoietic stem and progenitor mobilization. Leukemia 2011; 25: 211–217.
Lévesque JP, Helwani FM, Winkler IG . The endosteal ‘osteoblastic’ niche and its role in hematopoietic stem cell homing and mobilization. Leukemia 2010; 24: 1979–1992.
Ratajczak MZ, Kim CH, Wojakowski W, Janowska-Wieczorek A, Kucia M, Ratajczak J . Innate immunity as orchestrator of stem cell mobilization. Leukemia 2010; 24: 1667–1675.
Ratajczak MZ . Spotlight series on stem cell mobilization: many hands on the ball, but who is the quarterback? Leukemia 2010; 24: 1665–1666.
Massberg S, Schaerli P, Knezevic-Maramica I, Köllnberger M, Tubo N, Moseman EA et al. Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell 2007; 131: 994–1008.
Dar A, Kollet O, Lapidot T . Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Exp Hematol 2006; 34: 967–975.
Seitz G, Boehmler AM, Kanz L, Möhle R . The role of sphingosine 1-phosphate receptors in the trafficking of hematopoietic progenitor cells. Ann NY Acad Sci 2005; 1044: 84–89.
Marquez-Curtis LA, Turner AR, Sridharan S, Ratajczak MZ, Janowska-Wieczorek A . The ins and outs of hematopoietic stem cells: studies to improve transplantation outcomes. Stem Cell Rev 2010; e-pub ahead of print 8 December 2010; doi: 10.1007/s12015-010-9212-8.
Allende ML, Tuymetova G, Lee BG, Bonifacino E, Wu YP, Proia RL . S1P1 receptor directs the release of immature B cells from bone marrow into blood. J Exp Med 2010; 207: 1113–1124.
Pereira JP, Xu Y, Cyster JG . A role for S1P and S1P1 in immature-B cell egress from mouse bone marrow. PLoS One 2010; 5: e9277.
Nadia Harun, Marilyn Thien, Julius G Juarez, Kenneth Francis Bradstock, Linda J Bendall . S1P1 Agonists for Use as Adjunct Mobilizing Agents 2010, ASH annual meeting, Abstract #826.
Granado MH, Gangoiti P, Ouro A, Arana L, González M, Trueba M et al. Ceramide 1-phosphate (C1P) promotes cell migration involvement of a specific C1P receptor. Cell Signal 2009; 21: 405–412.
Chen Y, Yang C, Jin N, Xie Z, Tang Y, Fei L et al. Terminal complement complex C5b-9-treated human monocyte-derived dendritic cells undergo maturation and induce Th1 polarization. Eur J Immunol 2007; 37: 167–176.
Rossi L, Manfredini R, Bertolini F, Ferrari D, Fogli M, Zini R et al. The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration. Blood 2007; 109: 533–542.
Pelus LM, Hoggatt J, Singh P . Pulse exposure of hematopoietic grafts to prostaglandin E2 in vitro facilitates engraftment and recovery. Cell Prolif 2011; 44: 22–29.
Pettus BJ, Kitatani K, Chalfant CE, Taha TA, Kawamori T, Bielawski J et al. The coordination of prostaglandin E2 production by sphingosine-1-phosphate and ceramide-1-phosphate. Mol Pharmacol 2005; 68: 330–335.
Corallini F, Bossi F, Gonelli A, Tripodo C, Castellino G, Mollnes TE et al. The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis. Rheumatology (Oxford) 2009; 48: 293–298.
Luster AD, Alon R, von Andrian UH . Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol 2005; 6: 1182–1190.
Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004; 10: 858–864.
Bastianutto C, Mian A, Symes J, Mocanu J, Alajez N, Sleep G et al. Local radiotherapy induces homing of hematopoietic stem cells to the irradiated bone marrow. Cancer Res 2007; 67: 10112–10116.
Acknowledgements
This study was supported by NIH Grants R01 CA106281 and R01 DK074720, the Stella and Henry Endowment and the European Union structural funds (Innovative Economy Operational Program POIG.01.01.02-00-109/09-00) to MZR.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Leukemia website
Rights and permissions
About this article
Cite this article
Kim, C., Wu, W., Wysoczynski, M. et al. Conditioning for hematopoietic transplantation activates the complement cascade and induces a proteolytic environment in bone marrow: a novel role for bioactive lipids and soluble C5b-C9 as homing factors. Leukemia 26, 106–116 (2012). https://doi.org/10.1038/leu.2011.185
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2011.185
Keywords
This article is cited by
-
Intracellular complement (complosome) is expressed in hematopoietic stem/progenitor cells (HSPCs) and regulates cell trafficking, metabolism and proliferation in an intracrine Nlrp3 inflammasome-dependent manner
Leukemia (2023)
-
Hematopoietic stem cells on the crossroad between purinergic signaling and innate immunity
Purinergic Signalling (2023)
-
Hematopoiesis and innate immunity: an inseparable couple for good and bad times, bound together by an hormetic relationship
Leukemia (2022)
-
The P2X4 purinergic receptor has emerged as a potent regulator of hematopoietic stem/progenitor cell mobilization and homing—a novel view of P2X4 and P2X7 receptor interaction in orchestrating stem cell trafficking
Leukemia (2022)
-
Novel Evidence That Alternative Pathway of Complement Cascade Activation is Required for Optimal Homing and Engraftment of Hematopoietic Stem/progenitor Cells
Stem Cell Reviews and Reports (2022)